>
US Embassies Across Mideast Are Permanently Reassigning Personnel
GOA Members Make History With First Suppressor Transfers Without NFA Registration Since 1934
Common Blood Pressure Drug Recalled Nationwide, FDA Says
Will AstraZeneca Have to Pay Medical Expenses for Woman Injured During COVID Vaccine Trial?
Vitalik Buterin Says Ethereum Is Betting Its Future On Quantum Security And AI
Everything You Wanted To Know About Building A Cheap AI Setup (That Still Works)...
If They Were Human, They'd Be Arrested. Experts Respond To Rogue AI Breaches
Sodium Ion Batteries Will be 80% Cheaper & Last LONGER!
German startup SAXON Q has introduced a diamond-based quantum computing system...
Elon Musk To Build The Largest Building In The World - 100 Million Square Feet
Bitcoin 'Red Team' Says AI Is Finding 100s Of Critical Exploits Across Core Projects
EG4 Power Pro VS Ruixu Lithi VS Yixiang Budget Battery! Best Selling Battery Showdown!
Insect wings can kill bacteria without any chemicals!
Tesla Never Made An Electric Jet Boat, So This YouTuber Built One Himself

Retinitis pigmentosa (RP) is a genetic eye condition that results in damage to the retina. It has no cure; over time, a person with RP loses much or all of their vision.
But scientists have gotten one step closer to finding a better treatment. Researchers at the RIKEN Institute in Japan have now succeeded in growing retinal tissue and transplanting that tissue into the retinas of rhesus monkeys with RP. Three weeks after the treatment, visual tests on two of the monkeys found their vision had improved.
In the study, published this week in the journal PNAS, researchers grew retinal tissue from stem cells and then transplanted the tissue into the retinal area of rats with advanced RP. The tissue grew and in some cases adhered to the cells already in the retina and formed connections—a key factor in the success of this approach.